A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.

A randomized phase II trial was performed to compare the efficacy and toxicity of interleukin 2 (IL-2) with an IL-2 and interferon alpha (IFN-alpha) regimen for the treatment of metastatic renal carcinoma. Sixty patients with recurrent renal cell carcinoma (RCC) who had previously undergone a nephre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayson, G. C., Middleton, M., Lee, S. M., Ashcroft, L., Thatcher, N.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063040/
https://www.ncbi.nlm.nih.gov/pubmed/9703284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063040/
https://www.ncbi.nlm.nih.gov/pubmed/9703284

Ejemplares similares